A Multicenter, Open-Label Trial to Evaluate the Safety and Efficacy of the Sufentanil Sublingual Tablet 30 mcg in Patients With Post-Operative Pain

Clinical trial NCT02662556 · COMPLETED

Trial details

NCT number: NCT02662556
Sponsor: Talphera, Inc
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Acute Moderate-to-severe Pain

Start date: 2016-03-01
Primary completion: 2016-06-01
Enrollment: 140

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.